Barclays Sticks to Their Buy Rating for Alphatec Holdings (ATEC)

In a report released today, Matt Miksic from Barclays maintained a Buy rating on Alphatec Holdings, with a price target of $27.00.

Claim 70% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Miksic covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Johnson & Johnson, and Medtronic. According to TipRanks, Miksic has an average return of 3.3% and a 52.75% success rate on recommended stocks.

In addition to Barclays, Alphatec Holdings also received a Buy from Stifel Nicolaus’s Thomas Stephan in a report issued on March 9. However, today, TipRanks – PerPlexity reiterated a Hold rating on Alphatec Holdings (NASDAQ: ATEC).

Based on Alphatec Holdings’ latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $212.93 million and a GAAP net loss of $21.73 million. In comparison, last year the company earned a revenue of $176.79 million and had a GAAP net loss of $33.33 million

Based on the recent corporate insider activity of 86 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ATEC in relation to earlier this year. Earlier this month, Craig Hunsaker, the EVP, PEOPLE & CULTURE of ATEC sold 82,765.00 shares for a total of $1,030,424.25.